Home Tags Treatment
Treatment Related Content
25 NHS trusts will receive a share of the £26 million to replace outdated paper systems and introduce digital prescriptions.
The Keep Antibiotics Working campaign is back to alert the public to the risks of antibiotic resistance, urging people to always take their doctor, pharmacist or nurse’s advice.
Sam Mountney, Senior Policy & Campaigns Officer at Epilepsy Action, shares his expertise on cannabis-based medicines as a treatment for epilepsy in the UK.
For a long time the causes of acute coronary syndromes were poorly understood, and, only after the publication of our paper on New England Journal of Medicine on the importance of inflammation it was recognised as a crucial pathogenetic mechanism.
Regina Fluhrer from the University of Augsburg and Bernd Schröder from the TU in Dresden discuss the potential of intramembrane proteases as targets for cancer therapies.
Jenny Hirst MBE, Co-Chair, highlights the charitable work involved at InDependent Diabetes Trust to support people living with diabetes in the UK.
The NHS reports that 1 in 5 women in the UK are currently affected by PCOS, but what do we really know about the condition? It’s imperative that women have a clear understanding of their reproductive health. here, we explain everything you need to know about PCOS.
A new £2.6 million project led by Swansea University Medical School aims to dramatically improve the diagnosis and treatment of ovarian cancer.
Michael Morrison, Senior Researcher in Social Science at the Centre for Health, Law and Emerging Technologies (HeLEX), University of Oxford, sheds light on the promises as well as biomodifying technologies for the UK.
Jaime Essed, Founder and CEO of the company Oh My Mood, turns the spotlight onto Recovery-focused mental healthcare.
Dr Gerry Morrow shares his thoughts on the precision medicine, defined as the cost-effectiveness of breakthrough treatments and explains why this area is a priority for both researchers and government.
PillTime Ltd highlights the importance of medication management for diabetes as it remains a significant burden on the NHS.
Patients will benefit from significant government investment in new NHS technology to improve treatment, diagnosis and care options for diseases including cancer.
Maria Piggin, Chair of PNH Support tells us about the rare disease, paroxysmal nocturnal haemoglobinuria (PNH) and in this area, collaborations for change.
Dr Elizabeth Robertson, Director of Research at Diabetes UK details the hunt for an alternative to century-old Type 1 diabetes treatment – and looks at how British diabetes research is demanding something better.
A new test developed at Queen's University could allow ovarian cancer to be diagnosed at a stage up to two years earlier than current methods.
NHS England will fund treatment for thousands of people with severe Haemophilia, which will lessen the risk of life-threatening Haemophilia bleeds and reduce treatment time.
Pete Tate, CEO and Founder of MedTate, explains the role of nutraceuticals in preventing illness when it comes to diabetes in the UK.
Research from the Nuffield Department of Population Health, University of Oxford, supported by Diabetes UK, has shown that helping people with Type 2 diabetes to meet their three treatment targets could lead to significant savings for the NHS.
Chief Executive of Brain Tumour Research, Sue Farrington Smith MBE, outlines the priorities for research into brain tumours and why it is imperative we overcome this uniquely devastating cancer.